1Pearson TA, Mensah GA, Alexander RW. Markers of inflammation and cardiovascular disease: application to clinical and public health practice:A statement for heahhcare professionals from the Centers for Disease Control and Prevention and the American Heart Association[J]. Circulation, 2003,107(3) :499-511.
2Recasena M, Ricart W, Fernandez-Real JM. Obesity and inflammation[J]. Rev Med Univ Navarra, 2004,48(2) :49-54.
5Wallace SM, Yasmin L, McEniery CM, et al. Isolate systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction[J]. Hypertension, 2007, 50(1): 228-233.
6Zhnag QX, Magovem C,J, Mack CA, et al. Vascular endothelial growth factor is the major angiogenic factor in omentum: Mechanism of the omentum mediated angiogenesis[ J]. J Surg Res, 1997,67:147.
7Vyzantiadis T, Karagiannis A, Douma S, et al. Vascular endothelial growth factor and nitric oxide serum levels in arterial hypertension [ J ]. Clin Exp Hypertens, 2006,28:603-609.
8Bautista LE, Lopes JP, Vera LM, et al. Is C-reactive protein an independent risk factor for essential hypertension[ J] ? J Hypertens, 2001, 19(5) : 857-861.
9Hayalshi-Okano R, Yamasaki Y, Katakami N, et al. Elevated C-reactive protein associates with early-stage carotid atheosclerosis in young subjects with type 1 diabetes[ J]. Diabetes Care, 2002, 25 ( 8 ) : 1432- 1438.
10Fichtlscherer S, Rosenberer G, Disk H, et al. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease[J]. Circulation, 2000,102(9) : 1000-1006.
3Mombouli JV, Vanhoutte PM. Endothelial dysfunction: from physiology to therapy. J Cellcardiol, 1999,31:61-74.
4Zhang H, Cook D. Cerebral smooth muscle potassium channel and their possible role in th management of vasospasm. Pharmacol Toxicol ,2004,75 (6) :327-336.
5Spencer CG, Martin SC, Felmeden DC, et al. Relationship of homocysteine to markers of platelet and endothelial activation in" high risk" hypertensives : a substudy of the Anglog Scandinavian Cardiac Outcomes Trail. Int J Cardiol,2007,94(223 ) :293-300.
6Xenos ES, Stevens SL, Freeman MB, et al, Nitric oxidemediates the effect of fluvastatin on intercellular adhesion molecule and platelet endothelial cell adhesion molecule expression on human endothelial cells. Ann Vasc Surg,2007,19(3):386-392,.
7Johnson FK, Johnson RA, Peyton K J, et al. Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension. Am J Physiol Regul Integr Comp Physiol, 2005,288 (4) : R1057-1062.
8Rekhviashvili A, Tsinamdzgvrishvili B, Chkhetia M, et al. The relationship between endothelial dysfunction and 24-hour blood pressure rhythm in patients with arter/al hypertension. Georgian Med News, 2008,155 : 13-17.
9Wallace SM, Yasmin L, MeEniery CM, et al. Isolate systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction. Hypertension,2007,50 : 228-233.
10Khan SS, Solomon MA, McCoy JP Jr, et al. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom, 2005,64 ( 1 ) : 1-8.
9Inrig JK, Van Buren P, Kim C, et al. Probing the mechanisms of in tradialytic hypertension： A pilot study targeting endothelial cell dysfunction[J]. Clin J Am Soc Nephrol,2012,7(8) : 1300 - 17;09.
10Quaschning T, Voss F, Ielle K ,et al. Lack of endothelial nitric ox ide synthase promotes endothelin - induced hypertension l.essons from endothelin - 1 transgenic/endothelial nitric oxide synthase knockout mice[J]. J Am Soc Nephrol,2007,18(3)730- 740.
